Ultra Violette Secures Investment to Expand Retail Footprint
Ultra Violette has secured investment from consumer growth equity firm Aria Growth Partners to fuel its international expansion plans.
The Australian sunscreen brand will use the funds to expand its presence in North America and will enter Sephora stores in Canada in March 2024. The investment will also be used for further product and team development.
This is the first time Ultra Violette has received outside capital since co-founders Ava Chandler-Matthews and Rebecca Jefferd launched the brand in 2019.
Ultra Violette offers SPF-infused products for face, body and lips. Stocked in 28 international markets across Europe, Australia, UK, Asia and the Middle East. Ultra Violette reportedly achieves 100% year-on-year growth every year.
"This investment marks an important milestone for our business," said Jefferd. "We are confident that it will be remembered as the start of something greater than we could have ever imagined. Through our expansion so far, we have been overwhelmed by the response to our product formulations, but we have only just scratched the surface."added Jefferd.
Jackie Dunklau, co-founder and partner at Aria Growth Partners, said, "Rebecca and Ava are impressive entrepreneurs who have created a beautiful brand with truly amazing high-performing products. As consumers change their SPF habits from occasion-based to everyday use, Ultra Violette is well-positioned to lead the way. "
2026-10-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
-
Wanhua Chemical Expands TPU Production by 200,000 Tons with RMB 287 Million Investment
-
“The Agency Revolution”: BASF Breaks Into Dongfeng Liuzhou’s Supply Chain
-
Braskem Weighs Out-of-Court Restructuring as $10 Billion Debt Burden Deepens Petrochemical Crisis
Recommend Reading
-
Ancora Offers Up to $1.2 Billion for H.B. Fuller Building Adhesives Business
-
“Strategic Amputation” or “Phoenix Rebirth”? AkzoNobel’s Global Retreat and a $25 Billion Gamble
-
Unable to Buy Entire AkzoNobel, Nippon Paint Begins a "Disassembled Approach"
-
Covestro Builds New 660,000-ton MDI Plant in China: Global Supply Gap Meets Chinese Overcapacity Head-On
-
BASF Commits to Safeguarding Jobs at the Ludwigshafen Site Through 2028 with Multi-Billion-Euro Investments
-
Business Society’s Market Outlook for MIBK on August 11, 2026: Tending to Weak
-
Business Society’s EVA Market Outlook on August 11, 2026: Short-Term Price Decline
-
Cost Support: Shandong Cyclohexanone Sees a Pullback in Operations
-
Business Society August 11, 2026 Caustic Soda Market View: Weak Consolidation
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic